论文部分内容阅读
目的探讨肠内营养在治疗重症急性胰腺炎患者中的临床应用价值。方法将2004年10月至2010年10月收治的68例重症急性胰腺炎患者随机分为两组,对照组34例给予常规治疗,治疗组34例在此基础上接受肠内营养支持治疗,观察两组的治疗结果及临床指标的变化。结果治疗后治疗组的血清清蛋白(36±5)g/L及前清蛋白(248±54)g/L均明显高于对照组,差异有统计学意义(P(0.05);治疗组的血淀粉酶恢复时间(5.1±1.4)d、尿淀粉酶恢复时间(8.6±1.7)d、住院时间(23±8)d、并发症发生率(14.7%)、病死率(8.8%)均短于对照组,差异有统计学意义(P<0.05)。结论肠内营养是重症急性胰腺炎患者的一种安全、有效的治疗方式,方法简单,容易操作,可有效提高其治愈率,降低病死率和并发症发生率,缩短病程,减少医疗费用。
Objective To investigate the clinical value of enteral nutrition in the treatment of patients with severe acute pancreatitis. Methods Seventy-eight patients with severe acute pancreatitis admitted to our hospital from October 2004 to October 2010 were randomly divided into two groups, 34 patients in the control group were treated routinely, 34 patients in the treatment group received enteral nutrition support on this basis Treatment outcome and clinical changes in both groups. Results After treatment, the levels of serum albumin (36 ± 5) g / L and pre-albumin (248 ± 54) g / L in the treatment group were significantly higher than those in the control group (P <0.05) Blood amylase recovery time (5.1 ± 1.4) d, urinary amylase recovery time (8.6 ± 1.7) d, hospital stay (23 ± 8) d, complication rate (14.7%) and fatality rate (P <0.05) .Conclusion Enteral nutrition is a safe and effective treatment for patients with severe acute pancreatitis. The method is simple and easy to operate, which can effectively improve the cure rate and reduce the incidence of death Rates and complications, shorten the course of the disease, reduce medical costs.